Quintiles.com

  • About the Quintiles Experts

    • John Doyle, Dr. P.H.

      Senior Vice President and Managing Director for Global Market Access & Commercialization, Consulting, Quintiles

      John Doyle, Dr.P.H., MPH, is Senior Vice President and Managing Director for Global Market Access & Commercialization with Consulting at Quintiles. Dr. Doyle's consulting practice leads the focus on helping life sciences companies maximize the commercial success of their products through market access strategy and evidence-based research. Functional areas of expertise include health economic and outcomes research, pricing and reimbursement, health technology assessment, and comparative effectiveness research.

      Read full biography

    • Patrick Jordan

      Vice President, Payer and Provider Solutions

      Patrick Jordan is Vice President and Head of Operations of Quintiles Payer and Provider Solutions, a division of the organization that partners with hospital systems, payers and health authorities to improve the quality and cost of healthcare delivery. He has 20 years of healthcare experience in building and leading teams in corporate development, operations, informatics product management, and partnership management in the biopharmaceutical industry.

      Read full biography

    • Brian Kelly

      President, Payer & Provider Solutions

      Dr. Brian Kelly joined Quintiles in 2012 to lead the company's Payer and Provider Solutions businesses. In this global role, Dr. Kelly is responsible for leading the development and execution of Quintiles' business strategy for these market segments.

      Read full biography


  • About This Report

    Quintiles launched its industry surveys and report in 2010 to offer perspective and insight into key topics that are relevant to our customers. Quintiles continues to commission regular surveys in an effort to better understand the dramatic changes that occur within the drug development landscape. The Collaboration Mandate report is based on a survey of biopharmaceutical executives, managed care executives and providers in the US, and payer organization executives in France, Germany, Italy, Spain and the United Kingdom. Market Probe conducted the survey on behalf of Quintiles and was responsible for all survey design, data analysis and data reporting. Data for the survey were collected online between 30 April and 30 May, 2013. Survey sample respondents included: 102 biopharmaceutical executives at the vice president level and above; 68 managed care executives in the US at the director level and above; 75 executives (director or above) from European payer organizations; and 53 executives from US provider organizations.

    Download PDF | The Collaboration Mandate

    View Larger | Collaborative Success: One Benefit Does Not Fit All

    A systems-oriented approach to health care | Patrick Jordan

    View Larger

    View Larger | Barriers to Collaboration

    Challenges of adopting a systems-oriented approach | Dr. Brian Kelly

    Data integration | Dr. Brian Kelly

    View Larger

    View Larger | The Promise of Integration

    Demonstrating value | Dr. Brian Kelly

    View Larger

    A systems-oriented approach to health care | Dr. Brian Kelly

    View Larger

    View Larger

    View Larger | Bridging the Gap

    Data integration | Patrick Jordan



    Forward-Looking Statements
    This site and its related links, including videos, and other content may contain forward-looking statements that reflect, among other things, Quintiles' current thinking, expectations and ideas, all of which are subject to known and unknown risks, uncertainties and other factors that may cause market trends, industry results or Quintiles' actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. Any statements contained on this site or in its related links that are not statements of historical fact are forward-looking statements and should be evaluated as such. Without limiting the foregoing, the words "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "should," "targets," "will" and the negative thereof and similar words and expressions are intended to identify forward-looking statements. These statements are subject to risks, uncertainties and assumptions and are imprecise by their very nature. For more information regarding these risks as they may affect Quintiles, please see the risk factors identified in Quintiles' filings with the Securities and Exchange Commission, which are available in the Investors Relations section of Quintiles' website at www.quintiles.com. Unless legally required, Quintiles assumes no obligation to update any such forward-looking information to reflect actual results or changes in the factors affecting such forward-looking information.